Follow
Dr Kazeem Adeyinka Adeboyejo
Dr Kazeem Adeyinka Adeboyejo
Molecular Virologist, Olabisi Onabanjo University
Verified email at oouagoiwoye.edu.ng
Title
Cited by
Cited by
Year
Real-world outcomes of DAA treatment and retreatment in UK-based patients infected with HCV genotypes/subtypes endemic in Africa
E Aranday-Cortes, CP McClure, C Davis, WL Irving, K Adeboyejo, L Tong
J Infect Dis 226, 995-1004, 2021
62021
Real-world outcomes of direct-acting antiviral treatment and Retreatment in United Kingdom–based patients infected with hepatitis C virus Genotypes/subtypes Endemic in Africa
E Aranday-Cortes, CP McClure, C Davis, WL Irving, K Adeboyejo, L Tong, ...
The Journal of infectious diseases 226 (6), 995-1004, 2022
52022
Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil
K Adeboyejo, VR Grosche, DP José, GM Ferreira, JF Shimizu, BJ King, ...
Access Microbiology 4 (3), 000326, 2022
42022
In vitro Antimicrobial Activity of Clerodendron Polycephalum Against Clinical Bacterial Isolates
AM Deji-Agboola, FA Olajubu, KA Adeboyejo, OO Onakalu, HI Effedua, ...
Nigerian Medical Practitioner 55 (3), 2009
42009
Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination
K Adeboyejo, BJ King, T Tsoleridis, AW Tarr, J McLauchlan, WL Irving, ...
Journal of Medical Virology 95 (1), e28178, 2023
2023
Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
KA Adeboyejo
University of Nottingham, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–6